Shots: Arbutus discontinues its P-Ia/Ib study of AB-506 due to disappointing clinical findings i.e, observation of two cases of acute hepatitis in P-Ia clinical study assessing Ab-506 in healthy volunteers […]readmore
Tags : P-Ia/Ib
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Boehringer Ingelheim
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Lilly
Merck
Novartis
P-III
patients
Pfizer
receives
Regeneron
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
Treat
Treatment
US